Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma
Conditions
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- Nodal Marginal Zone Lymphoma
- Recurrent Grade 1 Follicular Lymphoma
- Recurrent Grade 2 Follicular Lymphoma
- Recurrent Mantle Cell Lymphoma
- Recurrent Small Lymphocytic Lymphoma
- Refractory Chronic Lymphocytic Leukemia
- Splenic Marginal Zone Lymphoma
- Waldenstrom Macroglobulinemia
Interventions
- DRUG: Bortezomib
- BIOLOGICAL: Rituximab
- DRUG: Cyclophosphamide
- DRUG: Dexamethasone
- OTHER: Questionnaire Administration
- OTHER: Quality-of-Life Assessment
Sponsor
Mayo Clinic
Collaborators